Key Takeaways from the SEC’s 2025 Exam Priorities

The Securities and Exchange Commission (SEC) has unveiled its examination priorities for 2025, focusing on key areas such as investment advisers, broker-dealers, cybersecurity, and crypto assets. This announcement, detailed by Eric Mikkelson and Carissa Occhipinto from Stinson LLP, provides a roadmap for registered investment advisers, investment companies, and broker-dealers to prepare for potential examinations.

Investment Advisers

The SEC’s Division of Examinations continues to emphasize the importance of fiduciary duties. Investment advisers must adhere to fiduciary standards, ensuring they act in the best interests of their clients. The Division will scrutinize compliance programs, particularly for advisers integrating artificial intelligence into their operations.

Broker-Dealers

Broker-dealers are under the spotlight with the continued enforcement of Regulation Best Interest. The Division will assess whether broker-dealers make recommendations that are in the best interests of their clients, with a keen eye on complex and high-risk products. Compliance with Form CRS, which provides crucial information about broker-dealers to retail investors, remains a top priority.

Cybersecurity and Crypto Assets

Cybersecurity measures are critical as the Division seeks to prevent service interruptions and protect investor information. The evolving landscape of crypto assets also demands attention, with examinations focusing on whether registrants adhere to standards of conduct and maintain robust compliance practices.

Emerging Risks

The Division highlights potential risks in financial technologies, particularly the use of AI and digital engagement practices. Firms must ensure their representations about AI capabilities are accurate and that they have adequate controls in place.
For more detailed insights, you can view the full original article on Stinson LLP’s website.
As the SEC navigates these priorities amidst a changing presidential administration, registrants are advised to conduct thorough reviews and consult with counsel to ensure compliance and readiness for the year ahead.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Gene Editing: A Promising Frontier in Biotechnology

Gene editing technology is swiftly emerging as a transformative force in both healthcare and agriculture, particularly through tools like CRISPR-Cas9, which offer precise methods to modify genes and promise to revolutionize treatment for genetic disorders, cancer, and infectious diseases.

Empowering the Gig Economy: AXA’s Tailored Protection

Angela Wong, Chief Marketing and Customer Officer at AXA Hong Kong & Macau, underscores the critical need for comprehensive insurance solutions for gig workers.

By |November 24, 2024|Categories: Article, Business, Insurance|Tags: , |0 Comments

Ethical Deployment of AI in Healthcare: AMA’s Guiding Strategies

The AMA highlights that AI's integration must be guided by the fundamental principles of medical ethics: patient autonomy, beneficence, nonmaleficence, and justice.

By |November 24, 2024|Categories: Article, Healthcare, Technology Ethics|Tags: , |0 Comments

AI’s Role in Revolutionizing Medical Education

AI, which simulates human intelligence, is reshaping various sectors, particularly healthcare. The ability to perform complex tasks, such as diagnostics and personalized healthcare, is no longer confined to human capabilities alone.

By |November 23, 2024|Categories: Article, Education, Technology|Tags: , |0 Comments

AI Chatbots in Chronic Disease Diagnosis

A recent study published in Nature on July 25, 2024, unveils a cutting-edge chatbot named Chat Ella, designed to assist in the diagnosis of chronic diseases.

Revolutionizing Genetic Research with CRISPR-Cas Technology

CRISPR-Cas technology is not just a tool but a gateway to understanding the genetic influences on diseases.